Publication | Open Access
Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas
91
Citations
22
References
2022
Year
Targeting mitochondrial metabolism and ISR activation effectively impairs DMG tumorigenicity. These results supported the initiation of two pediatric clinical trials (NCT05009992, NCT04732065).
| Year | Citations | |
|---|---|---|
Page 1
Page 1